pembrolizumab,mrna-4157
merck,moderna
['key,note,42', 'mrna-4157', 'key,note,57', 'key,note,45', 'keynote,942', 'melanoma', 'pembro']
#cedarssinaicancer at #aacr23. dr. mark faries is co-author on a study of a cancer vaccine, mrna-4157, combined with #pembrolizumab vs pembrolizumab in patients with resected high-risk #melanoma (keynote-942 trial) presented at 9:45am pt. 
Cedars-Sinai Cancer, ranked #9 in the nation in 2021 by U.S. News & World Report.